IPCA-Prochlorperazine

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Prochlorperazine maleate 5 mg
Available from:
Ipca Pharma (NZ) Pty Limited
INN (International Name):
Prochlorperazine maleate 5 mg
Dosage:
5 mg
Pharmaceutical form:
Tablet
Composition:
Active: Prochlorperazine maleate 5 mg Excipient: Colloidal silicon dioxide Lactose monohydrate Magnesium stearate Maize starch
Prescription type:
Prescription
Manufactured by:
Trifarma SpA
Therapeutic indications:
Prochlorperazine maleate is used in vertigo due to Meniere's syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.
Product summary:
Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 250 tablets - 24 months from date of manufacture stored at or below 25°C
Authorization number:
TT50-9337
Authorization date:
2013-06-27

Similar products

Search alerts related to this product

Share this information